- €56.34m
- €58.73m
- €132.21m
- 97
- 59
- 64
- 88
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 72.3 | 85.9 | 98.4 | 121 | 132 |
Cost of Revenue | |||||
Gross Profit | 61.7 | 70.6 | 81.6 | 98.5 | 109 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 68.7 | 81.6 | 94 | 116 | 127 |
Operating Profit | 3.6 | 4.28 | 4.44 | 4.86 | 5.14 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 3.61 | 4.04 | 4.42 | 4.78 | 5.01 |
Provision for Income Taxes | |||||
Net Income After Taxes | 2.58 | 2.79 | 3.12 | 3.29 | 3.7 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 1.97 | 1.94 | 2.37 | 2.39 | 2.71 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 1.97 | 1.94 | 2.37 | 2.39 | 2.71 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.223 | 0.208 | 0.25 | 0.252 | 0.306 |
Dividends per Share |